Cantor Fitzgerald started coverage on shares of Skye Bioscience (NASDAQ:SKYE – Free Report) in a research report released on Thursday, Marketbeat reports. The brokerage issued an overweight rating and a $21.00 price target on the stock. SKYE has been the subject of a number of other research reports. Piper Sandler reissued an overweight rating and […]
Skye Bioscience (NASDAQ:SKYE – Get Free Report) is one of 1,000 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it compare to its competitors? We will compare Skye Bioscience to similar companies based on the strength of its profitability, dividends, risk, earnings, valuation, institutional ownership and analyst recommendations. Valuation & Earnings This table […]
Skye Bioscience (NASDAQ:SKYE) Posts Earnings Results, Misses Expectations By $0.02 EPS wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
Skye Bioscience, Inc.'s (NASDAQ:SKYE) last week's 13% decline must have disappointed private equity firms who have a significant stake yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Skye Bioscience, Inc.: Skye Bioscience Highlights Novel Synthetic Cannabinoid-based Library Capable of Modulating the Endocannabinoid System to Treat Ocular Diseases at ARVO 2024 Annual Meeting finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Skye Bioscience Highlights Novel Synthetic Cannabinoid-based Library Capable of Modulating the Endocannabinoid System to Treat Ocular Diseases at ARVO 2024 Annual Meeting tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Skye Bioscience (NASDAQ:SKYE) Shares Down 1.8% etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.
Skye Bioscience (SKYE) versus The Competition Financial Survey theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Skye Bioscience (NASDAQ:SKYE – Get Free Report) is one of 992 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it contrast to its competitors? We will compare Skye Bioscience to similar companies based on the strength of its valuation, institutional ownership, dividends, analyst recommendations, risk, profitability and earnings. Insider & Institutional Ownership 21.1% […]
Skye Bioscience to Present Two Posters at Association for Research in Vision and Ophthalmology (ARVO) 2024 Annual Meeting tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.